Media Advisory - Federal Fleet Services - Opening of Halifax Operations Centre
HALIFAX, Dec. 7, 2017 /CNW/ - Spencer Fraser, Chief Executive Officer of Federal Fleet Services will open the organization's Halifax Operations Centre.
The operations centre will facilitate the day-to-day work of the MV ASTERIX, a Resolve Class Naval Support Ship leased to the Royal Canadian Navy. The MV ASTERIX will provide the navy with fuel, cargo, ammunition, a floating hospital, a platform for two helicopters and quarters for humanitarian and rescue operations.
Date: December 8, 2017
Time: 10:15 a.m.
Location: Suite 300 1209 Marginal Road Halifax, Nova Scotia B3H 4P8
Following opening remarks Mr. Fraser will be available for interviews and the office space will be open for tours.
Members of the media who wish to confirm their attendance or to receive additional information should contact:
Pomerantz LLP is investigating claims on behalf of investors of Li Auto Inc. ("Li Auto" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....
Ralph & Pat Plumb, owners of the Brick Alley Pub, announced today that they've entered into an agreement to sell the Brick Alley Pub to The Heritage Restaurant Group, formerly 1899 Ventures, a Newport Rhode Island based restaurant group.
The Brick...
Pomerantz LLP is investigating claims on behalf of investors of SeaStar Medical Holding Corporation ("SeaStar" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....
Pomerantz LLP is investigating claims on behalf of investors of Perion Network Ltd. ("Perion" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....
Pomerantz LLP is investigating claims on behalf of investors of TMC the metals company Inc. ("TMC" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. ...
Pomerantz LLP is investigating claims on behalf of investors of Zevra Therapeutics, Inc. ("Zevra" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....
